ARTUSI, CARLO ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 2.051
AS - Asia 1.177
EU - Europa 979
Continente sconosciuto - Info sul continente non disponibili 208
SA - Sud America 133
AF - Africa 66
OC - Oceania 5
Totale 4.619
Nazione #
US - Stati Uniti d'America 1.984
SG - Singapore 501
RU - Federazione Russa 397
IT - Italia 340
CN - Cina 183
VN - Vietnam 156
HK - Hong Kong 114
BD - Bangladesh 96
BR - Brasile 95
GB - Regno Unito 53
DE - Germania 37
FR - Francia 34
CA - Canada 27
FI - Finlandia 23
NL - Olanda 23
IN - India 18
MX - Messico 17
ID - Indonesia 16
KR - Corea 15
IQ - Iraq 14
ZA - Sudafrica 13
NG - Nigeria 12
BJ - Benin 11
ES - Italia 10
PK - Pakistan 10
AR - Argentina 9
AT - Austria 9
IE - Irlanda 9
JP - Giappone 9
SE - Svezia 9
SA - Arabia Saudita 8
TG - Togo 8
TR - Turchia 8
EC - Ecuador 7
PL - Polonia 7
VE - Venezuela 7
MY - Malesia 6
PH - Filippine 6
UA - Ucraina 6
AU - Australia 5
CH - Svizzera 5
DZ - Algeria 5
JM - Giamaica 5
CO - Colombia 4
MA - Marocco 4
PE - Perù 4
CL - Cile 3
EG - Egitto 3
HN - Honduras 3
NI - Nicaragua 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
BE - Belgio 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GE - Georgia 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
RO - Romania 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
LY - Libia 1
MD - Moldavia 1
NA - Namibia 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SL - Sierra Leone 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 4.411
Città #
Dallas 634
San Jose 520
Singapore 330
Council Bluffs 221
Verona 183
Ashburn 176
Moscow 146
Hong Kong 107
Ho Chi Minh City 55
New York 45
Hanoi 40
Beijing 34
Milan 30
Santa Clara 27
Buffalo 25
Los Angeles 25
The Dalles 18
London 14
Bologna 13
Chandler 13
São Paulo 12
Cotonou 11
Rome 11
Abuja 10
Helsinki 10
Lappeenranta 10
Amsterdam 9
Haiphong 9
Jakarta 9
Da Nang 8
Dublin 8
Lomé 8
Redondo Beach 8
Nuremberg 7
Phoenix 7
Southend 7
Tokyo 7
Toronto 7
Baghdad 6
Brooklyn 6
Chicago 6
Mexico City 6
Montreal 6
Munich 6
Biên Hòa 5
Cape Town 5
Caracas 5
Des Moines 5
Geneva 5
Redmond 5
Turin 5
Vienna 5
Atlanta 4
Falkenstein 4
Jacksonville 4
Kuala Lumpur 4
Madrid 4
Manchester 4
Naples 4
North Bergen 4
Poplar 4
Riyadh 4
Stockholm 4
Warsaw 4
Algiers 3
Belo Horizonte 3
City of London 3
Denver 3
Dhaka 3
Glasgow 3
Guangzhou 3
Islamabad 3
Jeddah 3
Kyiv 3
Las Vegas 3
Lawrence 3
Managua 3
Marseille 3
Orem 3
Philadelphia 3
Princeton 3
Rio de Janeiro 3
San Salvador 3
Santo André 3
Sydney 3
Turku 3
Ankara 2
Asunción 2
Bergamo 2
Birmingham 2
Bordeaux 2
Boston 2
Boydton 2
Brasília 2
Cairo 2
Camden 2
Can Tho 2
Catania 2
Changsha 2
Columbus 2
Totale 3.032
Nome #
The Influence of Genetics in the Early Development of Axial Postural Abnormalities in Parkinson's Disease 366
The Complex Pathway of Conventional Investigations before the Diagnosis of Functional Motor Disorders 355
Camera- and Viewpoint-Agnostic Evaluation of Axial Postural Abnormalities in People with Parkinson’s Disease through Augmented Human Pose Estimation 130
Assessment of axial postural abnormalities in Parkinsonism: automatic picture analysis software 130
Dynamic Video Assessment of Axial Postural Abnormalities in Parkinson's Disease: A Pilot Study 125
Advances in diagnosis, classification, and management of pain in Parkinson's disease 121
Axial postural abnormalities in Parkinsonism: gaps in predictors, pathophysiology, and management 121
Freezing of gait detection: The effect of sensor type, position, activities, datasets, and machine learning model 121
Does the degree of trunk bending predict patient disability, motor impairment, falls, and back pain in Parkinson's Disease? 108
Postural abnormalities in Parkinson's Disease: an epidemiological and clinical multicenter study 106
Task force consensus on nosology and cut-off values for axial postural abnormalities in parkinsonism 102
Clinical Algorithm-Guided Approach to Botulinum Toxin Type A Treatment for Axial Postural Abnormalities in Parkinson's Disease 102
Botulinum toxin for axial postural abnormalities in Parkinson's Disease: a systematic review 100
Validity of the wall goniometer as a screening tool to detect postural abnormalities in Parkinson's disease 97
Predictors and pathophysiology of axial postural abnormalities in Parkinsonism: a scoping review 96
Longitudinal assessment of Botulinum Toxin treatment for lateral trunk flexion and Pisa Syndrome in Parkinson's Disease: real-life, long-term study 96
Visuospatial Deficits Are Associated with Pisa Syndrome and not Camptocormia in Parkinson's Disease 79
Filling the gap in assessing pain in dystonia 73
Reply: "Human Pose Estimation Is Approximate: Limitations and Considerations for its Use in Clinical Trials" 72
Treatment of axial postural abnormalities in parkinsonism disorders: A systematic review of pharmacological, rehabilitative and surgical interventions 72
A multi-level annotated sensor dataset of gait freezing manifestations and severity in Parkinson's disease 42
Placebo Responses in Trials of Functional Neurologic Disorders 41
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation 37
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations 37
Is segmental/multifocal onset a distinct presentation of idiopathic adult-onset dystonia? 35
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant 28
Does sex influence the natural history of idiopathic adult-onset dystonia? 27
From RGB-D to RGB-Only: Reliability and Clinical Relevance of Markerless Skeletal Tracking for Postural Assessment in Parkinson’s Disease 25
Gait and axial postural abnormalities correlations in Parkinson{'}s disease: A multicenter quantitative study 25
A new index to assess turning quality and postural stability in patients with Parkinson{'}s disease 24
Digital work engagement among Italian neurologists 23
Clinical MRI to predict motor and non-motor effects of deep brain stimulation in Parkinson disease 22
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials 22
Burden of caregiving for cardiovascular dysautonomia in Parkinson?s disease 22
Biomechanical assessment of botulinum toxin effects in Pisa syndrome disease 22
Long-term motor and cognitive outcome of Deep Brain Stimulation in GBA-PD: the Italian PARKNET study 22
Unraveling the stride: exploring the influence of neurogenic orthostatic hypotension on gait and balance in Parkinson?s disease 22
Speech Impairment in Parkinson's Disease: Acoustic Analysis of Unvoiced Consonants in Italian Native Speakers 22
NoMoFa as a new tool to evaluate the impact of deep brain stimulation on non-motor fluctuations: A new perspective 21
Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab 21
Low frequency subthalamic stimulation and event-related potentials in Parkinson disease 21
Editorial: Digital biomarkers in movement disorders 21
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson?s disease 21
Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis 20
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson?s disease patient with Parkin gene mutation: a case report 20
Nonmotor fluctuations in Parkinson's disease: impact on caregiving and quality of life 20
Effect of deep brain stimulation frequency on gait symmetry, smoothness and variability using IMU 20
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up 20
Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life 20
Incidence and predictors of postural abnormalities in Parkinson?s disease: a PPMI cohort study 20
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson?s disease patients 20
Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study 19
Detection of Freezing of Gait in People with Parkinson{'}s Disease using Smartphones 19
Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson{'}s disease 19
(Re)configuration of digital health records to optimize diagnosis and therapy 18
Smartphone-Based Evaluation of Postural Stability in Parkinson’s Disease Patients During Quiet Stance 18
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum 18
Expanded and independent validation of the NoMoFA scale for Parkinson?s disease: the Italian version 18
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel 18
The relationship between occupation and specific forms of idiopathic adult-onset dystonia 18
Ventral tegmental area disconnection contributes two years early to correctly classify patients converted to alzheimer's disease: Implications for treatment 17
Subthalamic and Nigral Stimulation for Freezing of Gait in Parkinson disease: randomized pilot trial 17
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: A role for age at disease onset? 17
Identifying Poor Responders to STN DBS in Parkinson Disease: The Role of Rapid Disease Progression in the First Year in Optimal Responders to Levodopa 17
Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson?s disease 17
Tuning deep brain stimulation related depression by frequency modulation: A case report 17
Ultrasound-guided botulinum toxin-a injections: A method of treating sialorrhea 17
The still under-investigated role of cognitive deficits in PML diagnosis 17
Subthalamic deep brain stimulation and levodopa in Parkinson?s disease: a meta-analysis of combined effects 17
Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson{'}s disease 17
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: Effects on involuntary movements 17
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 17
Natalizumab in multiple sclerosis: Long-term management 16
Should we offer deep brain stimulation to Parkinson?s disease patients with GBA mutations? 16
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 16
Subthalamic deep brain stimulation and trunk posture in Parkinson's disease 16
Deep Brain Stimulation Selection Criteria for Parkinson's Disease: Time to Go beyond CAPSIT-PD 16
Behind the scenes: exploring neurological journal editors{'} work habits, decisions, and potential sources of conflict of interest 16
Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors 16
Postural abnormalities in Asian and Caucasian Parkinson{\textquotesingle}s disease patients: A multicenter study 16
Pisa syndrome in Parkinson's disease is associated with specific cognitive alterations 16
Parkinsonism-hyperpyrexia syndrome due to gastroparesis treated with subcutaneous foslevodopa: a case report 16
Levodopa-Induced Neuropathy: A Systematic Review 16
Orthostatic hypotension in Parkinson disease: Impact on health care utilization 15
Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech 15
Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases 15
CACNA1A variant associated with generalized dystonia 15
Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild {COVID}-19 infection 15
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson{'}s disease: A different long-term outcome? 15
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review 15
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: A 7-year experience 15
G325R GBA mutation in Parkinson's disease: Disease course and long- term DBS outcome 15
Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach 15
Parkinson{'}s disease progression at 30 years: A study of subthalamic deep brain-stimulated patients 14
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study 14
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 14
COVID-19 in Parkinson's disease: Report on prevalence and outcome 14
Telemedicine in Neurological Disorders: Opportunities and Challenges 13
Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients 13
Theta-Gamma Subthalamic Stimulation for Verbal Fluency in Parkinson{'}s Disease: A Randomized, Crossover Trial 13
Totale 4.125
Categoria #
all - tutte 24.173
article - articoli 23.860
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 313
Totale 48.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213 0 3 0 0 0 0 0 2 0 1 2 5
2022/202351 3 8 4 5 4 10 1 2 3 4 4 3
2023/202478 5 3 6 9 8 21 8 2 0 4 6 6
2024/2025306 16 11 16 42 15 6 15 23 41 24 30 67
2025/20263.884 70 63 644 180 426 110 151 1.015 520 383 143 179
2026/2027242 202 40 0 0 0 0 0 0 0 0 0 0
Totale 4.619